FINANCIAL CONSULATE, INC

Position in BMY — Bristol Myers Squibb Co

CIK 1624510 HUNT VALLEY, MD

Position in BMY

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$90,578

-$9,251 QoQ

Shares Held

1,572

-4.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#2,253

of 2,506 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 49% Shared 0% None 51%

Healthcare · as of Jun 30, 2026

FINANCIAL CONSULATE, INC holds $4,839,565 across 15 Drug Manufacturers - General names. BMY ranks #7 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,232	$1,477,697
2	MRK	Merck & Co., Inc.	7,599	$976,471
3	JNJ	Johnson & Johnson	3,667	$931,307
4	ABBV	AbbVie Inc.	3,167	$796,943
5	AZN	Astrazeneca PLC	870	$164,969
6	AMGN	Amgen Inc	445	$161,143
7	BMY	Bristol Myers Squibb Co This page	1,572	$90,578
8	NVS	Novartis AG	515	$80,710

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$90,578	1,572	-4.5%	Shares	Sole	2026-07-23
2026-03-31	$99,829	1,646	-40.1%	Shares	Sole	2026-04-21
2025-12-31	$148,335	2,750	-5.1%	Shares	Sole	2026-01-22
2025-09-30	$130,699	2,898	-14.0%	Shares	Sole	2025-10-21
2023-03-31	$233,574	3,370	+6.6%	Shares	Other	2023-04-17
2022-12-31	$227,362	3,160	0.0%	Shares	Other	2023-01-11
2022-09-30	$224,644	3,160	0.0%	Shares	Other	2022-10-20
2022-06-30	$243,320	3,160	0.0%	Shares	Other	2022-07-19
2022-03-31	$230,774	3,160	-0.1%	Shares	Other	2022-04-28
2021-06-30	$211,284	3,162	-5.2%	Shares	Other	2021-07-22
2021-03-31	$210,664	3,337	0.0%	Shares	Other	2021-04-19
2020-12-31	$206,994	3,337	+0.8%	Shares	Other	2021-01-29
2020-09-30	$199,680	3,312	-9.4%	Shares	Other	2020-10-20
2020-06-30	$215,031	3,657	-3.3%	Shares	Other	2020-07-22
2020-03-31	$210,808	3,782	—	Shares	Other	2020-04-29
No filing history on record for this holder in this stock.